- Home
- MDIA vs BRNS Comparison
MDIA vs BRNS Comparison
Compare MDIA & BRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDIA
- BRNS
- Stock Information
- Founded
- MDIA 2019
- BRNS 2016
- Country
- MDIA United States
- BRNS United Kingdom
- Employees
- MDIA N/A
- BRNS N/A
- Industry
- MDIA Broadcasting
- BRNS Biotechnology: Pharmaceutical Preparations
- Sector
- MDIA Consumer Discretionary
- BRNS Health Care
- Exchange
- MDIA Nasdaq
- BRNS Nasdaq
- Market Cap
- MDIA 69.2M
- BRNS 58.0M
- IPO Year
- MDIA N/A
- BRNS 2021
- Fundamental
- Price
- MDIA $1.24
- BRNS $1.61
- Analyst Decision
- MDIA
- BRNS Strong Buy
- Analyst Count
- MDIA 0
- BRNS 1
- Target Price
- MDIA N/A
- BRNS $3.00
- AVG Volume (30 Days)
- MDIA 135.2K
- BRNS 248.2K
- Earning Date
- MDIA 11-13-2025
- BRNS 11-05-2025
- Dividend Yield
- MDIA N/A
- BRNS N/A
- EPS Growth
- MDIA N/A
- BRNS N/A
- EPS
- MDIA 0.40
- BRNS N/A
- Revenue
- MDIA $121,938,000.00
- BRNS $14,969,000.00
- Revenue This Year
- MDIA N/A
- BRNS N/A
- Revenue Next Year
- MDIA N/A
- BRNS N/A
- P/E Ratio
- MDIA $3.14
- BRNS N/A
- Revenue Growth
- MDIA 165.75
- BRNS 1766.46
- 52 Week Low
- MDIA $0.79
- BRNS $0.64
- 52 Week High
- MDIA $2.28
- BRNS $2.92
- Technical
- Relative Strength Index (RSI)
- MDIA 40.32
- BRNS 65.26
- Support Level
- MDIA $1.23
- BRNS $1.36
- Resistance Level
- MDIA $1.29
- BRNS $1.67
- Average True Range (ATR)
- MDIA 0.05
- BRNS 0.17
- MACD
- MDIA -0.01
- BRNS 0.05
- Stochastic Oscillator
- MDIA 22.33
- BRNS 72.15
About MDIA Mediaco Holding Inc.
MediaCo Holding Inc is a radio broadcasting media company operating in radio and digital advertising, premium programming, and events. It has two radio stations, WQHT-FM and WBLS-FM, which serve the New York City metropolitan area. The company generates revenue from radio and outdoor advertising sales, events including sponsorships and ticket sales, licensing, and syndication. The company has two business segments: the Audio segment and the Video segment. The company generates the majority of its revenue from the Audio segment.
About BRNS Barinthus Biotherapeutics plc
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutics that guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. The company operates as one segment, the research and development of immunotherapies and vaccines.